Acne Treatment Pads
Generic Name: acne treatment pads
Brand Names:
Acne Treatment Pads
Purpose Acne Treatment
Overview
Purpose Acne Treatment
Uses
Use Helps reduce acne blemishes Helps keep pores clear
Dosage
Directions Clean and dry the affected area before use. Apply the patch to the affected area with dry hands. Gently press to ensure adhesion. Remove the patch after up to 6-8 hours of use.
Side Effects
Skin irritation and dryness may occur if you use anothertopical acne product at the same time.Stop use and aska doctor if irritation becomes severe If there is irritation, stop using it immediately.
Warnings
Warnings For external use only Do not use If you are allergic to this product, please do not use it.
Storage
Other information Store at room temperature Protect from excessive heat and humidity
Frequently Asked Questions
What is Acne Treatment Pads used for?▼
Use Helps reduce acne blemishes Helps keep pores clear
What are the side effects of Acne Treatment Pads?▼
Skin irritation and dryness may occur if you use anothertopical acne product at the same time.Stop use and aska doctor if irritation becomes severe If there is irritation, stop using it immediately.
What are the important warnings for Acne Treatment Pads?▼
Warnings For external use only Do not use If you are allergic to this product, please do not use it.
Related Medications
Duvelisib
duvelisib
11 DESCRIPTION COPIKTRA (duvelisib) is a kinase inhibitor. Duvelisib is a white-to-off-white crystalline solid with the empirical formula C 22 H 17 ClN 6 O•H 2 O and a molecular weight of 434.88 g/mol. Hydration can vary with relative humidity. Duvelisib contains a single chiral center as ( S ) enantiomer. Duvelisib is soluble in ethanol and practically insoluble in water.
Quizartinib Dihydrochloride
quizartinib dihydrochloride
Dosage form: TABLET, FILM COATED. Active ingredients: QUIZARTINIB DIHYDROCHLORIDE (17.7 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Velpatasvir And Sofosbuvir
velpatasvir and sofosbuvir
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
11 DESCRIPTION Sofosbuvir and velpatasvir tablets (400 mg/100 mg) are fixed-dose combination tablets containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor. Each tablet contains 400 mg sofosbuvir and 100 mg velpatasvir. The tablets include the following inactive ingredients: copovidone, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.